Fawley helps in COVID-19 fight
Halobutyl rubber creates a strong, impermeable barrier which lends itself perfectly for use in the production of pharmaceutical bottle stoppers to keep medicines sealed and sterile. The rubber creates a re-sealable barrier, which does not fragment when pierced by the needle of syringe, as required for a COVID-19 vaccine vial.
Jamie Renshaw, Fawley’s Chemicals technical manager, says: “By providing approximately 70 per cent of all ExxonMobil pharmaceutical grade rubber, Fawley is making a significant contribution to the COVID-19 vaccine supply chain. In fact, we believe that around half of all the rubber that goes into the vial stoppers globally may originate from Fawley!”
Fawley’s Chemicals plant also produces a range of liquids that are being used in the manufacture of medical products, including sterile packaging and cleaning agents. The site also manufactures plasticisers which are used in hospital flooring, protective goggles, vinyl gloves, facemasks and respirators.
Jamie added: “As we are all only too aware, COVID-19 continues to be a massive global challenge, affecting whole populations in ways that most of us would not have predicted just over a year ago. Throughout the pandemic, ExxonMobil Fawley has remained a reliable supplier to the pharmaceutical industry, making sure that we play our part in the fight against this disease.”